Background Eisenmenger syndrome (ES) is a severe and fatal complication of uncorrected congenital heart disease characterised ...

The gene therapy market for ocular rare diseases is expanding rapidly as breakthroughs in viral vectors (like AAV) and gene-editing tools enable one-time, disease-modifying treatments for previously ...

TG Therapeutics, Inc. has seen rapid enrolment of ENHANCE study, which could allow simplified dosing regime of IV Briumvi.

MED Holdings Group Inc. (OTC:YUKA) today announced the acquisition of TotallBody.com, a new telehealth platform designed to deliver comprehensive wellness, weight loss, hormone therapy, and longevity ...

The owner of LED-light therapy mask CurrentBody--which listed on the London Stock Exchange last month--on Wednesday attributed its performance to an ever-increasing awareness of the at-home ...

Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory ...

Chris Hemsworth discovered something alarming a few years ago: The same DNA that helped the Australian actor achieve the ...

The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...

A major new clinical trial involving more than 1,600 people has found that a GLP-1 pill form of the drug orforglipron works ...

(Reuters) -Australian biotech firm CSL said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived therapies, in a move to expand its footprint in the North American country ...

Final 5-year data from the phase 2 2102-HEM-101 trial (NCT02719574) show that olutasidenib (Rezlidhia) delivered sustained ...

THROUGH NOV. 30 Valor to Victory Specialty Tours — to honor America’s greatest athletes who have also served in the Armed Forces, noon, U.S. Olympic & Paralympic Museum, 200 S. Sierra Madre St., go ...